These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32687115)

  • 1. Comparison of clinical efficacy of long- versus short-acting gonadotrophin-releasing hormone agonists for pituitary down regulation in
    Umemmuo MU; Efetie ER; Agboghoroma CO; Momoh JA; Ikechebelu JI
    Niger Postgrad Med J; 2020; 27(3):171-176. PubMed ID: 32687115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
    Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotrophin-releasing hormone antagonists for assisted conception.
    Al-Inany H; Aboulghar M
    Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.
    El-Nemr A; Bhide M; Khalifa Y; Al-Mizyen E; Gillott C; Lower AM; Al-Shawaf T; Grudzinskas JG
    Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):140-5. PubMed ID: 12069736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Westergaard LW; Bossuyt PM; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003973. PubMed ID: 21328264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI.
    Westergaard LG; Yding Andersen C; Erb K; Laursen SB; Rasmussen PE; Rex S; Teisner B
    Reprod Biomed Online; 2004 Jan; 8(1):91-8. PubMed ID: 14759294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F
    Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles.
    Cheon KW; Song SJ; Choi BC; Lee SC; Lee HB; Yu SY; Yoo KJ
    J Korean Med Sci; 2008 Aug; 23(4):662-6. PubMed ID: 18756054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
    J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments.
    Maldonado LG; Franco JG; Setti AS; Iaconelli A; Borges E
    Fertil Steril; 2013 May; 99(6):1615-22. PubMed ID: 23394779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
    Testart J; Forman R; Belaisch-Allart J; Volante M; Hazout A; Strubb N; Frydman R
    Hum Reprod; 1989 Feb; 4(2):198-201. PubMed ID: 2521866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-control study on reduced-dose depot versus daily administration of gonadotrophin-releasing hormone agonists for pituitary desensitization in in vitro fertilization cycles.
    Gao J; Xu YW; Miao BY; Zhou CQ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1901-6. PubMed ID: 25056469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.